Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept (PoC) Evaluation of Naloxone Unique Intramuscular (IM) Injection

NCT07180420 is registered in ClinicalTrials.gov with STAT Therapeutics Inc as lead sponsor.

NCT NCT07180420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept (PoC) Evaluation of Naloxone Unique Intramuscular (IM) Injection
Lead sponsor
STAT Therapeutics Inc
Phase
Phase 1
Overall status
Completed
Start date
March 24, 2024
Completion date
April 8, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer - complete